ES2062065T3 - Composicion farmaceutica para la prevencion de enfermedades que son transmisibles sexualmente. - Google Patents

Composicion farmaceutica para la prevencion de enfermedades que son transmisibles sexualmente.

Info

Publication number
ES2062065T3
ES2062065T3 ES89401979T ES89401979T ES2062065T3 ES 2062065 T3 ES2062065 T3 ES 2062065T3 ES 89401979 T ES89401979 T ES 89401979T ES 89401979 T ES89401979 T ES 89401979T ES 2062065 T3 ES2062065 T3 ES 2062065T3
Authority
ES
Spain
Prior art keywords
prevention
sexually
pharmaceutical composition
diseases
communicable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89401979T
Other languages
English (en)
Inventor
Jacques Julien Augros
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sspl SA Safe Sex Prod Licens
Safe Sex Products Licensing SSPL SA
Original Assignee
Sspl SA Safe Sex Prod Licens
Safe Sex Products Licensing SSPL SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sspl SA Safe Sex Prod Licens, Safe Sex Products Licensing SSPL SA filed Critical Sspl SA Safe Sex Prod Licens
Application granted granted Critical
Publication of ES2062065T3 publication Critical patent/ES2062065T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

LA COMPOSICION FARMACEUTICA PARA LA PREVENCION DE ENFERMEDADES TRANSMISIBLES SEXUALMENTE SEGUN LA INVENCION ESTA DESTINADA A SER PUESTA EN CONTACTO CON UNA MUCOSA. ESTA CARACTERIZADA PORQUE CONTIENE, POR UNA PARTE, POR LO MENOS UN PRINCIPIO ACTIVO CONTRA VIRUS Y BACTERIAS RESPONSABLES DE DICHAS ENFERMEDADES TRANSMISIBLES SEXUALMENTE Y, POR OTRA PARTE, UN PRODUCTO INHIBIDOR DE PENETRACION DE DICHO PRINCIPIO ACTIVO A TRAVES DE UNA MUCOSA, EN COMBINACION CON UN VEHICULO FARMACEUTICAMENTE ACEPTABLE, ADAPTADO PARA UNA ADMINISTRACION POR VIA TOPICA DE ESTA COMPOSICION. PREFERIBLEMENTE, EL PRODUCTO INHIBIDOR DE PENETRACION ES UN FILMOGENO, APTO PARA FORMAR UNA PELICULA A LA QUE ESTAN ASOCIADOS EL O LOS PRINCIPIOS ACTIVOS.
ES89401979T 1988-07-11 1989-07-10 Composicion farmaceutica para la prevencion de enfermedades que son transmisibles sexualmente. Expired - Lifetime ES2062065T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8809418 1988-07-11

Publications (1)

Publication Number Publication Date
ES2062065T3 true ES2062065T3 (es) 1994-12-16

Family

ID=9368330

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89401979T Expired - Lifetime ES2062065T3 (es) 1988-07-11 1989-07-10 Composicion farmaceutica para la prevencion de enfermedades que son transmisibles sexualmente.

Country Status (38)

Country Link
US (1) US5439685A (es)
EP (1) EP0351301B1 (es)
JP (1) JPH0774164B2 (es)
KR (1) KR0143231B1 (es)
CN (1) CN1035038C (es)
AP (1) AP108A (es)
AR (1) AR243381A1 (es)
AT (1) ATE97570T1 (es)
BR (1) BR8903523A (es)
CA (1) CA1341304C (es)
CZ (1) CZ280722B6 (es)
DD (1) DD283932A5 (es)
DE (1) DE68910892T2 (es)
DK (1) DK173527B1 (es)
ES (1) ES2062065T3 (es)
FI (1) FI101595B1 (es)
HK (1) HK131095A (es)
HU (1) HU206634B (es)
IE (1) IE63115B1 (es)
IL (1) IL90910A (es)
LT (1) LT3754B (es)
LV (1) LV10573B (es)
MA (1) MA22036A1 (es)
MD (1) MD406C2 (es)
MX (1) MX170801B (es)
MY (1) MY106242A (es)
NO (1) NO178843C (es)
NZ (1) NZ229891A (es)
OA (1) OA09123A (es)
PL (1) PL161848B1 (es)
PT (1) PT91108B (es)
RU (1) RU2065742C1 (es)
SK (1) SK278614B6 (es)
TN (1) TNSN89074A1 (es)
TR (1) TR28353A (es)
UA (1) UA26124A (es)
YU (1) YU47899B (es)
ZA (1) ZA895263B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5795870A (en) * 1991-12-13 1998-08-18 Trustees Of Princeton University Compositions and methods for cell transformation
US5693769A (en) * 1991-12-13 1997-12-02 Transcell Technologies, Inc. Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
IT1255450B (it) * 1992-06-30 1995-10-31 Montefarmaco Spa Uso di acidi biliari come agenti antivirali
EP0773029A4 (en) * 1993-07-19 1997-09-03 Tokyo Tanabe Co HEPATITIS C VIRUS PROLIFERATION INHIBITOR
DE4341139C1 (de) * 1993-12-02 1995-04-13 Upmeyer Hans Juergen Dimeticon zur Behandlung von Aphthen
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
FR2728464B1 (fr) * 1994-12-22 1997-04-30 Innothera Lab Sa Forme galenique unitaire, son procede d'obtention et ses utilisations
US5700679A (en) * 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
GB2318292A (en) * 1996-09-12 1998-04-22 Simon Everard Barton Saliva-like protectants
US6287286B1 (en) * 1998-08-25 2001-09-11 Kimberly-Clark Worldwide, Inc. Absorbent article having a reduced viability of candida albicans
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
FR2803208A1 (fr) * 1999-12-29 2001-07-06 Jean Bastien Pasquini Tampon periodique antiseptique et son procede de preparation
AU2001243431B2 (en) * 2000-03-07 2006-05-25 Rush University Medical Center Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
GB2414394B (en) * 2001-04-11 2006-01-11 Playtex Products Inc Use of a catamenial tampon which comprises a non-ionic surfactant for the treatment of vaginal malodour
GB2415626B (en) * 2001-04-11 2006-03-08 Playtex Products Inc Use of a catamenial tampon which comprises a cationic surfactant for the treatment of vaginal malodor
US8093446B2 (en) * 2001-04-11 2012-01-10 Playtex Products, Inc. Fibrous absorbent articles having malodor counteractant
SE0102152L (sv) * 2001-06-18 2002-12-19 Sca Hygiene Prod Ab Ny produkt
ATE289514T1 (de) * 2003-11-03 2005-03-15 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
BRPI0615411A2 (pt) * 2005-08-29 2012-12-04 Sepsicure L L C uso de um ácido da bìlis ou de um sal de ácido da bìlis e um fosfolipìdeo
DE102006020644A1 (de) * 2006-04-28 2007-10-31 Bayer Innovation Gmbh Antiseptikahaltige Silikonelastomere
US8062631B2 (en) 2006-09-28 2011-11-22 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US8409557B2 (en) 2006-09-28 2013-04-02 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
AU2012203566B1 (en) * 2008-03-27 2013-09-12 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
KR101130754B1 (ko) 2010-06-25 2012-03-28 제일약품주식회사 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물
CN103298519B (zh) * 2010-11-12 2016-09-14 犹他大学研究基金会 用于受控式润滑剂传递的阴道内装置
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
AU2012245665B2 (en) 2011-04-19 2017-06-15 Arms Pharmaceutical Llc. Method of inhibiting harmful microorganisms and barrier-forming composition therefor
CA2781379C (en) 2012-03-26 2013-09-03 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
WO2021138156A1 (en) 2019-12-30 2021-07-08 ARMS Pharmaceutical LLC Biofilm prevention and treatment
DE102020131233A1 (de) * 2020-11-25 2022-05-25 Netzsch Trockenmahltechnik Gmbh Verfahren zur herstellung eines homogenisierten gemischs aus kohlenstoff, schwefel und ptfe
KR102399883B1 (ko) * 2021-02-09 2022-05-20 재단법인대구경북과학기술원 압출용 복합고분자 펠릿 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1161484A (en) * 1965-08-20 1969-08-13 Mediline Ag Toilet Preparation
SE353658B (es) * 1967-06-13 1973-02-12 Dow Corning
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3770648A (en) * 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US4393871A (en) * 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4228797A (en) * 1978-09-25 1980-10-21 Dickey Richard P Intravaginal contraception method
ZA827582B (en) * 1981-11-06 1983-08-31 Ansell Inc Spermicidal condom
JPS58103453A (ja) * 1981-12-07 1983-06-20 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド １−置換イミダゾ−ルを放出する使い捨て膣内避妊具
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
AU2272883A (en) * 1982-12-22 1984-06-28 Herpes Pharmaceutical Inc. Pharmaceutical compositions of steriods for treatment of herpes simplex infections
DE3346641A1 (de) * 1983-12-23 1985-07-04 Dynamit Nobel Ag, 5210 Troisdorf Silanmodifizierte estergemische
GB8402748D0 (en) * 1984-02-02 1984-03-07 Dunlop Ltd Intravaginal device
NL8600929A (nl) * 1986-04-11 1987-11-02 Fundatech Sa Werkwijze voor het vervaardigen van een gemedicateerd wegwerp-pessarium en gemedicateerd wegwerp-pessarium.
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
US4952411A (en) * 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
GB8706313D0 (en) * 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
FR2614525B1 (fr) * 1987-04-29 1995-11-10 Jacques Augros Tampon en eponge elastique, notamment tampon vaginal
US4922928A (en) * 1988-08-17 1990-05-08 Michael Burnhill Vaginal device

Also Published As

Publication number Publication date
RU2065742C1 (ru) 1996-08-27
AU3802689A (en) 1990-01-11
LV10573A (lv) 1995-04-20
IL90910A0 (en) 1990-02-09
MY106242A (en) 1995-04-29
IE892218L (en) 1990-01-11
US5439685A (en) 1995-08-08
TNSN89074A1 (fr) 1991-02-04
FI101595B (fi) 1998-07-31
KR900001366A (ko) 1990-02-27
FI893340A0 (fi) 1989-07-10
EP0351301A2 (fr) 1990-01-17
CZ423889A3 (en) 1995-12-13
PL161848B1 (pl) 1993-08-31
BR8903523A (pt) 1991-11-05
CZ280722B6 (cs) 1996-04-17
DD283932A5 (de) 1990-10-31
MA22036A1 (fr) 1991-10-01
EP0351301B1 (fr) 1993-11-24
IL90910A (en) 1994-12-29
DK340289A (da) 1990-01-12
PL280531A1 (en) 1990-05-28
FI893340L (fi) 1990-01-12
SK423889A3 (en) 1997-11-05
YU47899B (sh) 1996-05-20
JPH02167235A (ja) 1990-06-27
MX170801B (es) 1993-09-14
DK340289D0 (da) 1989-07-10
EP0351301A3 (en) 1990-12-19
DE68910892T2 (de) 1994-05-05
CN1041879A (zh) 1990-05-09
DK173527B1 (da) 2001-01-29
LT3754B (en) 1996-03-25
HK131095A (en) 1995-08-24
LTIP1660A (en) 1995-07-25
YU135789A (en) 1992-05-28
NO178843B (no) 1996-03-11
CN1035038C (zh) 1997-06-04
SK278614B6 (en) 1997-11-05
ATE97570T1 (de) 1993-12-15
DE68910892D1 (de) 1994-01-05
AP108A (en) 1991-02-23
PT91108A (pt) 1990-02-08
PT91108B (pt) 1995-01-31
IE63115B1 (en) 1995-03-22
AR243381A1 (es) 1993-08-31
JPH0774164B2 (ja) 1995-08-09
AU625716B2 (en) 1992-07-16
FI101595B1 (fi) 1998-07-31
NO892826D0 (no) 1989-07-07
NZ229891A (en) 1991-01-29
LV10573B (en) 1995-08-20
KR0143231B1 (ko) 1998-07-15
HUT50445A (en) 1990-02-28
NO178843C (no) 1996-06-19
OA09123A (fr) 1991-10-31
UA26124A (uk) 1999-06-07
CA1341304C (fr) 2001-10-09
AP8900133A0 (en) 1989-10-31
MD406C2 (ro) 1996-06-30
HU206634B (en) 1992-12-28
ZA895263B (en) 1991-03-27
NO892826L (no) 1990-01-12
TR28353A (tr) 1996-05-16

Similar Documents

Publication Publication Date Title
MX170801B (es) Composicion farmaceutica para la prevencion de las enfermedades sexualmente transmisibles
AR039130A2 (es) Metodo de administracion de un agente farmaceuticamente activo a un ojo humano
BR0212475A (pt) Composições farmacêuticas
PT100963A (pt) Composicoes farmaceuticas para aplicacao topica de elevada penetracao atraves da pele que compreendem certos polimeros nao-ionicos especificos
BR9206631A (pt) Sistema de maior penetração na pele para melhor administração tópica de medicamentos
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
MY100721A (en) Therapeutic agent.
BR9406893A (pt) Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
BR9908438A (pt) Tabletes de desintegração rápida
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
WO2004002999A3 (en) Modified 2' and 3' -nucleoside produgs for treating flaviridae infections
EP0679390A3 (en) Sprayable topical pharmaceutical compositions
BR0109779A (pt) Soluções moleculares hidrofìlicas dispersas de carvedilol
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
BR9607234A (pt) Grânulos mucoadesivos uso dos mesmos processo para sua preparação composição farmâceutica e uso da mesma
BR0014159A (pt) Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional
ES2098920T3 (es) Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina.
MX9710206A (es) Composicion farmaceutica de amiodarone para administracion parenteral.
IT1275816B1 (it) Composizioni farmaceutiche solide per uso vaginale
ES2130081B1 (es) Comprimido de maleato de trimebutina con recubrimiento laminar.
AR012868A1 (es) COMPOSICIoN FARMACÉUTICA QUE COMPRENDE UN PÉPTIDO AGONISTA DE LHRH, UN ANTAGONISTA DE LHRH O UN PÉPTIDO DE GRF Y NICOTINAMIDA.
IL100881A0 (en) Prophylactic devices for destruction of the human immunodeficiency virus during sexual relations
CA2504872A1 (en) Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
WO2003011249A3 (en) Ophthalmic composition containing n-acetylcysteine for the treat ment of dry-eye syndrome

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 351301

Country of ref document: ES